FDA Grants Approval for Gallium Ga-68 Gozetotide (ANDA216410)
The FDA has granted approval for the ANDA216410 application for Gallium Ga-68 Gozetotide submitted by Radiomedix.
Therapeutic Area
Therapeutic area intelligence for Radiopharmaceutical with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.